AlphaFold predicted structure
TEAD1 · P28347

Mean pLDDT
76.5/ 100
Confident
426 residues
Confidence breakdown
- Very high(≥ 90)47%
- Confident(70–90)20%
- Low(50–70)12%
- Very low(< 50)22%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
TEA domain transcription factor 1
Annotations refreshed 1 month ago.
Moderate Evidence (Amber)
Retinal disorders
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedhelicoid peripapillary chorioretinal degeneration
Abnormality of the skeletal system
osteoarthritis, knee
osteoarthritis, hand
osteoarthritis
medical procedure
neurodegenerative disease
osteoarthritis, hip
smoking initiation
intelligence
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Transcriptional enhancer factor TEF-1
Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds specifically and cooperatively to the SPH and GT-IIC 'enhansons' (5'-GTGGAATGT-3') and activates transcription in vivo in a cell-specific manner. The activation function appears to be mediated by a limiting cell-specific transcriptional intermediary factor (TIF). Involved in cardiac development. Binds to the M-CAT motif
Curated MONDO disease pages that list TEAD1 among their top associated genes.
TEAD1 · P28347

Mean pLDDT
76.5/ 100
Confident
426 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0